Ayako Hiraide-Sasagawa

Interleukin-4 and CpG oligonucleotide therapy suppresses the outgrowth of tumors by activating tumor-specific Th1-type immune responses.

M. Sakaki, M. Imawari, J. Eguchi, 2012, Oncology reports.

Increased expression of immuno‐inhibitory molecules on peripheral blood lymphocytes may suppress disease progression in autoimmune hepatitis

M. Shiina, M. Sakaki, M. Imawari, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.